Parkinson's Disease Clinical Trials in New York, New York

4 studies are recruiting for parkinson's disease in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Parkinson's Foundation PD GENEration Genetic Registry

   Development of a central repository for PD-related genomic data for future research.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mount Sinai, New York, New York

   Locations

   70 in total

   Run by

   Parkinson's Foundation

   See if you can join NCT04994015 on ClinicalTrials.gov

2. A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

   This is an observational study in which data are collected and studied from Parkinson's disease patients who have movement symptoms despite taking standard Parkinson's medications. In observational studies, observations are made without any changes to the participant's healthcare or treatment plan.…

   Stage

   Not phased

   Ages

   45 to 75

   Site

   Northwell Health, New York, New York

   Locations

   27 in total

   Run by

   Bayer

   See if you can join NCT07330258 on ClinicalTrials.gov

3. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

   The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

   Stage

   Phase 3

   Ages

   50 to 85

   Site

   Weill Cornell Medical College, New York, New York

   Locations

   192 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07174310 on ClinicalTrials.gov

4. A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

   The Goal of this study is to evaluate the safety, tolerability, and clinical responses following implantation of DSP-1083. Study enrolls both male and female patients in 2 cohorts. This study will be held in approximately 5-8 study sites in United States

   Stage

   Phase 1

   Ages

   40 to 72

   Site

   New York Presbyterian Hospital-Columbia University Medical Center, New York, New York

   Locations

   2 in total

   Run by

   Sumitomo Pharma America, Inc.

   See if you can join NCT06753331 on ClinicalTrials.gov